Charity seeks out non-drug approaches to treat Parkinson’s

Parkinson’s UK is launching a new funding program to support innovative studies into non-drug treatments for Parkinson’s.

This approach builds on Parkinson’s UK’s existing investment in many different non-pharmaceutical based therapies, including exercise, mindfulness, cognitive behavioral therapy, massage and reflexology.

Alongside medication, other approaches - such as living aids, exercise and therapies - can play a vital part in helping people to manage daily life and take control of the condition.

Every day, we hear from people with Parkinson’s who say that exercise alleviates their symptoms. On top of this, a growing body of evidence indicates physical activity may slow the condition’s progression. It is our mission to build on evidence like this and explore every possible avenue to improve the lives of people with Parkinson’s.

To date, Parkinson’s UK has invested more than £93 million in groundbreaking research and we want to continue leading the way.”

Professor David Dexter, Associate Director of Research at Parkinson’s UK

The charity is seeking research applications in this area. Non-drug approaches include but are not limited to:

  • Physiotherapy
  • Speech and language therapies
  • Non-drug-based mental health therapies
  • Complementary therapies
  • Nutrition
  • Exercise or dance
  • Technology and devices

Researchers are encouraged to contact Parkinson’s UK’s research team at [email protected] to apply. The duration of a non-drug approaches grant is for a maximum of two years.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration